ResourceDrug Discovery & Development
Enhancing drug candidate evaluation and clinical trial progression
18 Mar 2025AI is revolutionizing biopharmaceutical research and discovery, accelerating the process of evaluating drug candidates and progressing clinical trials. But these AI tools need vast amounts of data, and when that data is fragmented across systems, scientific organizations can experience workflow inefficiencies, compliance hurdles, and limited insight.
Using real-world examples of biopharma leaders using AI-powered solutions, learn why the AI revolution is making digital transformation in labs so important, and how AI-driven automation can drive faster results and enhance scientific discovery.
Links
Tags
Electronic Laboratory NotebooksElectronic Laboratory Notebooks (ELNs) are becoming increasingly popular for documenting experimental processes and for lab data management. An ELN is informatics software which can be biology specific, chemistry specific, cross-disciplinary or web-based. Advantages of an electronic lab notebook include increased data protection, efficiency and straightforward data searching and sharing.LIMSLIMS (Laboratory Information Management System) is an informatics software system used to improve the quality assurance and quality control (QA / QC) of data management. LIMS can be a standard for common lab workflows, such as commercial off the shelf systems (COTS), or customized for more specialized lab use. Systems are available for mainframe computers or PC.Software PlatformsSoftware platforms are useful for various stages of laboratory experiments from data collection to data storage and processing. For instance lab software is available for system control, data management, data analysis and qualification / validation.BiopharmaceuticalsBiopharmaceuticals are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or for in vivo diagnostics. The most well known example of a biopharmaceutical product, and the first to be approved for therapeutic use, was recombinant human insulin.